702 filings
Page 11 of 36
8-K
futkez0c858 hov
2 May 19
INBRIJA 1Q 2019 net sales of $1.3 million; approximately 2,000 prescription request forms received through April 2019
6:17am
8-K
h8gb61dm5hp9bp54cxbt
8 Mar 19
Acorda Therapeutics Announces Management Changes
7:11am
8-K
4n1taia jj2bh
28 Feb 19
Acorda Therapeutics Announces Commercial Launch of
12:00am
8-K
kamdc egbku01rg50s5
14 Feb 19
Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End 2018
12:00am
8-K
4m64xji qzr
4 Feb 19
Acorda Appoints Peter S. Carbone Senior Vice President, Quality
7:11am
8-K
gdzuiivlc
28 Jan 19
Departure of Directors or Certain Officers
12:00am
8-K
wf702njz
18 Jan 19
Other Events
12:00am
8-K
57fj g6ao92e
7 Jan 19
Results of Operations and Financial Condition
8:09am
8-K
we9aapi g3o8h
26 Dec 18
Other Events
6:12am
8-K
fezn4fk3s6xsicj
31 Oct 18
Acorda Provides Financial and Pipeline Update for Third Quarter 2018
6:52am
8-K
g9q 594xas3
18 Oct 18
Other Events
6:57am
8-K
rfbv98anj5g hhjsq5
13 Sep 18
U.S. Court of Appeals for the Federal Circuit Upholds District Court’s Decision to Invalidate AMPYRA® (dalfampridine) Patents
12:00am
UPLOAD
ng3dm7lqr
16 Aug 18
Letter from SEC
12:00am
CORRESP
faplu ldk
10 Aug 18
Correspondence with SEC
12:00am
S-3ASR
dg70fphmwdhu
8 Aug 18
Automatic shelf registration
5:13pm
S-8
zd8asiyrgveddbwc6
8 Aug 18
Registration of securities for employees
5:02pm